Literature DB >> 2138979

The lethal lambda S gene encodes its own inhibitor.

U Bläsi1, C Y Chang, M T Zagotta, K B Nam, R Young.   

Abstract

The 107 codon reading frame of the lambda lysis gene S begins with the codon sequence Met1-Lys2-Met3..., and it has been demonstrated in vitro that both Met codons are used for translational starts. Furthermore, the partition of initiation events at the two start codons strongly affects the scheduling of lysis. We have presented a model in which the longer product, S107, acts as an inhibitor of the shorter product, S105, the lethal lysis effector, despite the fact that the two molecules differ only in the Met-Lys residues at the amino terminus of S107. Using immunological and biochemical methods, we show in this report that the two predicted protein products, S105 and S107, are detectable in vivo as stable, membrane-bound molecules. We show that S107 acts as an inhibitor in trans, and that its inhibitory function is entirely defined by the positively charged Lys2 residue. Moreover, our data show that energy poisons abolish the inhibitory function of S107 and simultaneously convert S107 into a lysis effector. We propose a two step model for the lethal action of gene S: first, induction of the S gene results in the accumulation of S105 and S107 molecules in mixed oligomeric patches in the cytoplasmic membrane; second, S monomers rearrange by lateral diffusion within the patch to form an aqueous pore. The R gene product, a transglycosylase, is released through the pore to the periplasm, resulting in destruction of the peptidoglycan and bursting of the cell. According to this model, the lateral diffusion step is inhibited by the energized state of the membrane.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138979      PMCID: PMC551767          DOI: 10.1002/j.1460-2075.1990.tb08200.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

1.  pHG276: a multiple cloning site pBR322 copy number vector expressing a functional lac alpha peptide from the bacteriophage lambda PR promoter.

Authors:  G S Stewart; S Lubinsky-Mink; J Kuhn
Journal:  Plasmid       Date:  1986-05       Impact factor: 3.466

2.  Subcellular localization of lethal lysis proteins of bacteriophages lambda and phiX174.

Authors:  E Altman; K Young; J Garrett; R Altman; R Young
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Mutational analysis of bacteriophage lambda lysis gene S.

Authors:  R Raab; G Neal; J Garrett; R Grimaila; R Fusselman; R Young
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

4.  Lysis defective mutants of bacteriophage lambda: on the role of the S function in lysis.

Authors:  R W Reader; L Siminovitch
Journal:  Virology       Date:  1971-03       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Dominance in lambda S mutations and evidence for translational control.

Authors:  R Raab; G Neal; C Sohaskey; J Smith; R Young
Journal:  J Mol Biol       Date:  1988-01-05       Impact factor: 5.469

8.  Lysis defective mutants of bacteriophage lambda: genetics and physiology of S cistron mutants.

Authors:  R W Reader; L Siminovitch
Journal:  Virology       Date:  1971-03       Impact factor: 3.616

9.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

10.  Dual translational initiation sites control function of the lambda S gene.

Authors:  U Bläsi; K Nam; D Hartz; L Gold; R Young
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  36 in total

1.  The C-terminal sequence of the lambda holin constitutes a cytoplasmic regulatory domain.

Authors:  U Bläsi; P Fraisl; C Y Chang; N Zhang; R Young
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

2.  Dimerization between the holin and holin inhibitor of phage lambda.

Authors:  A Gründling; D L Smith; U Bläsi; R Young
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Holins kill without warning.

Authors:  A Gründling; M D Manson; R Young
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  Genetic and biochemical analysis of dimer and oligomer interactions of the lambda S holin.

Authors:  A Gründling; U Bläsi; R Young
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 5.  Bacteriophage lysis: mechanism and regulation.

Authors:  R Young
Journal:  Microbiol Rev       Date:  1992-09

6.  Dual start motif in two lambdoid S genes unrelated to lambda S.

Authors:  M T Bonovich; R Young
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

7.  Holin triggering in real time.

Authors:  Rebecca White; Shinobu Chiba; Ting Pang; Jill S Dewey; Christos G Savva; Andreas Holzenburg; Kit Pogliano; Ry Young
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

8.  The linear double-stranded DNA of phage Bam35 enters lysogenic host cells, but the late phage functions are suppressed.

Authors:  Ausra Gaidelyte; Silja T Jaatinen; Rimantas Daugelavicius; Jaana K H Bamford; Dennis H Bamford
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

9.  Periplasmic domains define holin-antiholin interactions in t4 lysis inhibition.

Authors:  Tram Anh T Tran; Douglas K Struck; Ry Young
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

Review 10.  Phage lysis: three steps, three choices, one outcome.

Authors:  Ryland Young
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.